Curis Inc (NASDAQ:CRIS)
| 10.93 Delayed Data As of Jan 22 |  -0.16 / -1.44%Today’s Change | 0.62 Today|||52-Week Range 13.44 | +33.46% Year-to-Date |
Latest CRIS News | Press Releases
No recent news for Curis Inc.
Today’s Trading
| Previous close | 11.09 |
| Today’s open | 11.11 |
| Day’s range | 10.79 - 11.48 |
| Volume | 45,898 |
| Average volume (3 months) | 6,420,355 |
| Market cap | $905.4M |
Data as of 3:59pm ET, 01/22/2021
Growth & Valuation
| Earnings growth (last year) | +1.51% |
| Earnings growth (this year) | +39.69% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -4.07% |
| P/E ratio | NM |
| Price/Sales | 5.64 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ADAPAdaptimmune Therapeu... | +0.17 | +3.14% |
| PTGXProtagonist Therapeu... | -1.18 | -5.01% |
| CDMOAvid Bioservices Inc | +0.62 | +4.55% |
| MRUSMerus NV | +0.15 | +0.55% |
Data as of 4:00pm ET, 01/22/2021
Financials
| Next reporting date | March 2, 2021 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $10.0M |
| Annual profit (last year) | -$32.1M |
| Net profit margin | -321.28% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Lexington, Massachusetts |
Forecasts
